London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
just a load of "he" said "she" said
Interesting. "Lawyers are only accepting claims from people who took brand name Zantac, and generic ranitidine is no longer included in lawsuits." https://www.drugwatch.com/zantac/lawsuits/
Can you really put a limit on the liability here with GSK? Millions of Zantac prescriptions were issued. From perusing a US lawyers website, 'The level of NDMA found in pills is 30,000 times the safe limit of 90uG and NDMA is deliberately used to cause cancer in lab rats as its such a good carcinogen. ' https://www.shouselaw.com/torts/zantac/
US lawyers are looking for people with very common cancers - eventually 50% of the population get cancer, and with a history of using Zantac ... looking over the past mega litigation vioxx and roundup cases - they are still settling them! The Roundup cases with Bayer is the nearest situation to this - the FDA claimed it was safe for 40 years, then, later, there is some evidence of NHL cancer associated with its use, which emerges in meta studies, still debated by Bayer scientists. The multi million jury damages awards start flying and haven't stopped. https://www.youtube.com/watch?v=83y-b7XmS7w
Hopefully she can do something with the share price like she did at S&N before it sinks any further.
Good start . was going to move more money to gdr after their RNS if a larger company looks at low price range of tests . Happy how GSK moving .
Rumour is that Julie Brown will be our new CFO.
https://uk.finance.yahoo.com/news/gsk-poaches-burberry-cfo-create-170600394.html
Thanks Mudeford.
At least you won’t need to actually wait until November for the upcoming 16.25p per share Quarterly dividend payment - it is due to be paid to shareholders on Thursday 6 October…
Thanks SJ74 & Mudeford but until it gets paid into my HL account I usual don’t believe it
Thanks Mudeford :)
The forecast dividend for the whole of 2023 is 56.25p per share. (The 45p figure quoted has been increased to reflect the Share Consolidation.)
GSK Press Release extract - 18 July 2022:
“Dividends
GSK has previously stated that it expected to declare a 27p per share dividend for the first half of 2022, a 22p per share dividend for the second half of 2022 and a 45p per share dividend for 2023, but that these targeted dividends per share would increase in step with the GSK Share Consolidation to maintain the same aggregate dividend pay-out in absolute Pound Sterling terms. Accordingly, using the consolidation ratio, GSK’s expected dividend for the second quarter of 2022 converts to 16.25p per new ordinary share (taking into account the dividend of 14p per share paid for the first quarter of 2022), the expected dividend for the second half of 2022 converts to 27.5p per new ordinary share and the expected dividend for 2023 converts to 56.25p per new ordinary share. GSK expects to publish its results for the second quarter of 2022 on Wednesday 27 July 2022 which will confirm the dividend to be declared for that quarter.”
It's 16.25p in November. From 2023 it will be 11.25p per quarter. 45p next year. They are resetting. I imagine it will grow quick though. More capital allocated to growth.
SJ74 How I read the GSK website you gave I calculate a div of 12.5p in November Should have done more work before I brought
Yeah still the same. This is taken from their recent circular over the summer. Just read the circular delivered to shareholders states first full year as new GSK allows for dividend of 45p in 2023.
New GSK progressive dividend policy starting at 45p in 2023
https://www.gsk.com/en-gb/media/press-releases/new-gsk-to-deliver-step-change-in-growth-and-performance-over-next-ten-years/
I got it from this. Unless it's changed since that's what's been in my mind. Bearing in mind that's the minimum and they are resetting to allow for growth I'm quite happy as that will grow.
sj74, found div infi on 'https://www.gsk.com/en-gb/investors/analyst-consensus/analyst-consensus/' - shows divs c 58p for 2022 and 2023 so I'll wait for sp 1200p before buying !!
Thanks sj74, 45p a bit low for all 2023 though.
With the SP so sh@te i might just have to buy more on this dip.....what could possibly go wrong !
Imagine if this wasn't a mini Black Friday - what would GSK have done - up today in a sea of red
45p for 2023 I think starting as a progressive divi policy.
Just wondering please, anyone know the GSK forecast BOD indicated Divs ?
Slowly slowly catchey monkey.
This is indication that buyers are stepping in. Couple that with my previous tweets of a big block purchase over 20M USD in the US a few days ago the signs are here. GSK will be going up leading to Christmas
Buy the dips was the advice I read over and over.....
Just added and other £3k ....I have every confidence that better times will return.
Me thinking that the split would do wonders for GSK......................what a load of pony !!!
Agreed.